Cargando…

p38 (MAPK) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes

Werner Syndrome (WS) is a human segmental progeria resulting from mutations in a DNA helicase. WS fibroblasts have a shortened replicative capacity, an aged appearance, and activated p38 MAPK, features that can be modulated by inhibition of the p38 pathway. Loss of the WRNp RecQ helicase has been sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Tivey, Hannah S. E., Brook, Amy J. C., Rokicki, Michal J., Kipling, David, Davis, Terence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627027/
https://www.ncbi.nlm.nih.gov/pubmed/23112078
http://dx.doi.org/10.1007/s10522-012-9407-2
_version_ 1782266282607902720
author Tivey, Hannah S. E.
Brook, Amy J. C.
Rokicki, Michal J.
Kipling, David
Davis, Terence
author_facet Tivey, Hannah S. E.
Brook, Amy J. C.
Rokicki, Michal J.
Kipling, David
Davis, Terence
author_sort Tivey, Hannah S. E.
collection PubMed
description Werner Syndrome (WS) is a human segmental progeria resulting from mutations in a DNA helicase. WS fibroblasts have a shortened replicative capacity, an aged appearance, and activated p38 MAPK, features that can be modulated by inhibition of the p38 pathway. Loss of the WRNp RecQ helicase has been shown to result in replicative stress, suggesting that a link between faulty DNA repair and stress-induced premature cellular senescence may lead to premature ageing in WS. Other progeroid syndromes that share overlapping pathophysiological features with WS also show defects in DNA processing, raising the possibility that faulty DNA repair, leading to replicative stress and premature cellular senescence, might be a more widespread feature of premature ageing syndromes. We therefore analysed replicative capacity, cellular morphology and p38 activation, and the effects of p38 inhibition, in fibroblasts from a range of progeroid syndromes. In general, populations of young fibroblasts from non-WS progeroid syndromes do not have a high level of cells with an enlarged morphology and F-actin stress fibres, unlike young WS cells, although this varies between strains. p38 activation and phosphorylated HSP27 levels generally correlate well with cellular morphology, and treatment with the p38 inhibitor SB203580 effects cellular morphology only in strains with enlarged cells and phosphorylated HSP27. For some syndromes fibroblast replicative capacity was within the normal range, whereas for others it was significantly shorter (e.g. HGPS and DKC). However, although in most cases SB203580 extended replicative capacity, with the exception of WS and DKC the magnitude of the effect was not significantly different from normal dermal fibroblasts. This suggests that stress-induced premature cellular senescence via p38 activation is restricted to a small subset of progeroid syndromes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10522-012-9407-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-3627027
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-36270272013-04-17 p38 (MAPK) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes Tivey, Hannah S. E. Brook, Amy J. C. Rokicki, Michal J. Kipling, David Davis, Terence Biogerontology Research Article Werner Syndrome (WS) is a human segmental progeria resulting from mutations in a DNA helicase. WS fibroblasts have a shortened replicative capacity, an aged appearance, and activated p38 MAPK, features that can be modulated by inhibition of the p38 pathway. Loss of the WRNp RecQ helicase has been shown to result in replicative stress, suggesting that a link between faulty DNA repair and stress-induced premature cellular senescence may lead to premature ageing in WS. Other progeroid syndromes that share overlapping pathophysiological features with WS also show defects in DNA processing, raising the possibility that faulty DNA repair, leading to replicative stress and premature cellular senescence, might be a more widespread feature of premature ageing syndromes. We therefore analysed replicative capacity, cellular morphology and p38 activation, and the effects of p38 inhibition, in fibroblasts from a range of progeroid syndromes. In general, populations of young fibroblasts from non-WS progeroid syndromes do not have a high level of cells with an enlarged morphology and F-actin stress fibres, unlike young WS cells, although this varies between strains. p38 activation and phosphorylated HSP27 levels generally correlate well with cellular morphology, and treatment with the p38 inhibitor SB203580 effects cellular morphology only in strains with enlarged cells and phosphorylated HSP27. For some syndromes fibroblast replicative capacity was within the normal range, whereas for others it was significantly shorter (e.g. HGPS and DKC). However, although in most cases SB203580 extended replicative capacity, with the exception of WS and DKC the magnitude of the effect was not significantly different from normal dermal fibroblasts. This suggests that stress-induced premature cellular senescence via p38 activation is restricted to a small subset of progeroid syndromes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10522-012-9407-2) contains supplementary material, which is available to authorized users. Springer Netherlands 2012-10-31 2013 /pmc/articles/PMC3627027/ /pubmed/23112078 http://dx.doi.org/10.1007/s10522-012-9407-2 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Research Article
Tivey, Hannah S. E.
Brook, Amy J. C.
Rokicki, Michal J.
Kipling, David
Davis, Terence
p38 (MAPK) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes
title p38 (MAPK) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes
title_full p38 (MAPK) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes
title_fullStr p38 (MAPK) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes
title_full_unstemmed p38 (MAPK) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes
title_short p38 (MAPK) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes
title_sort p38 (mapk) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627027/
https://www.ncbi.nlm.nih.gov/pubmed/23112078
http://dx.doi.org/10.1007/s10522-012-9407-2
work_keys_str_mv AT tiveyhannahse p38mapkstresssignallinginreplicativesenescenceinfibroblastsfromprogeroidandgenomicinstabilitysyndromes
AT brookamyjc p38mapkstresssignallinginreplicativesenescenceinfibroblastsfromprogeroidandgenomicinstabilitysyndromes
AT rokickimichalj p38mapkstresssignallinginreplicativesenescenceinfibroblastsfromprogeroidandgenomicinstabilitysyndromes
AT kiplingdavid p38mapkstresssignallinginreplicativesenescenceinfibroblastsfromprogeroidandgenomicinstabilitysyndromes
AT davisterence p38mapkstresssignallinginreplicativesenescenceinfibroblastsfromprogeroidandgenomicinstabilitysyndromes